Bernstein Initiates Coverage On LuxExperience with Outperform Rating, Announces Price Target of $12.9
Bernstein initiates coverage on LuxExperience (NYSE:LUXE) with a Outperform rating and announces Price Target of $12.9.
Economy · News reference
Market fear deepened as CNN’s index fell to 26; stocks mostly declined after the Fed’s rate hike, with the Dow dropping 631 points.
Reference Details
Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.
Keep reading
Bernstein initiates coverage on LuxExperience (NYSE:LUXE) with a Outperform rating and announces Price Target of $12.9.
B. Riley Securities analyst Anna Glaessgen maintains LuxExperience (NYSE:LUXE) with a Buy and raises the price target from $12 to $13.
JP Morgan analyst Matthew Boss maintains LuxExperience (NYSE:LUXE) with a Neutral and raises the price target from $9 to $10.
On October 13, 2026 (the "Effective Date"), DataMeds AI, Inc. ("DataMeds" or the "Company") entered into an Intellectual Property License and Product and Services Agreement (the "IP License
Filed: 2026-10-16 AccNo: 0001493152-26-047451 Size: 213 KB Item 1.01: Entry into a Material Definitive Agreement Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing Item 3.02: Unregistered Sales of Equity Securities